Site Search

Share

X

Search Results

The Costs of Cancer: ACS CAN 6th Annual New Mexico Cancer Summit

Please join us for the 6th annual New Mexico Cancer Summit. The 2019 NM Cancer Summit will examine the direct and indirect costs of cancer care during the patient journey. We will explore how benefit design, treatment plans and modalities, geographic location and other factors affect cancer patient costs and discuss what state and federal policymakers can do to help people maintain adequate and affordable access to care. PROGRAM MODERATOR: Dr. Jean McDougall, Assistant Professor, Department of Internal Medicine, University of New Mexico FEATURED GUEST SPEAKER: ... or 505-262-6019. Champion Sponsors: Bristol-Myers Squibb, Pfizer Community Sponsors: Celgene, Genentech, Janssen Oncology, PhRMA, Presbyterian Health Services In-Kind Sponsor: Resources for Change, Inc.     Contributions or membership payments to the American Cancer Society Cancer Action ...

Top Advocacy Volunteers Converge on Capitol Hill

This week, ACS CANŠ—Ès State Lead Ambassadors (SLA) have come to Washington DC to meet with their elected officials to advocate for health care reform that is easily accessible and affordable. To kick off ACS CAN's Lobby Day on Wednesday, a handful of SLA's will be outside the Capitol ... action, now not later, because cancer patients can't afford to wait. After all, if we can improve the system to provide equal access to quality care for cancer patients, we can improve the system for virtually everyone. Remember, if you are in or around the Washington, D.C. area make sure ...

Cancer Research Funding Passes Congress

... thatξACS CANξfought hard to see included. Cancer related provisions of the Omnibus include: $30.3 billion for the National Institutes of Health (NIH), an increase of $938 million, or 3.2 percent $4.96 billion of the NIH funding will go toward the National Cancer Institute, a $133 ... community-based program for colorectal cancer screening and treatment $4 million for the federal Patient Navigator Program run by the U.S. Health Resources and Services Administration, an initiative ACS CAN has long championed to place trained "navigators" in health facilities to assess patient and community needs, and guide patients through the health care system Cancer Research Funding Passes Congress ...

New Hampshire Virtual Cancer Action Week

... HB 1290, legislation that will study innovative biomarker testing for cancer patients? Biomarker testing is increasingly important for cancer care – and for the treatment of other diseases. Biomarker testing is important step for accessing precision medicine including targeted therapies ... non-academic medical centers are less likely to receive biomarker testing. A study like this will bring together leading experts from across the health care continuum and affords legislators and the public to engage in a public forum on a critical need in our state Vote no on SB 314 - ... and share the link to this page.  Materials: 2022 New Hampshire Priorities Biomarker Testing - Advancing Precision Medicine in Cancer Care Health Equity in Biomarker Testing and Targeted Theraphy     New Hampshire Virtual Cancer Action Week ...

Some Cancer Patients and Survivors Still Vulnerable Under New Regulation on External Appeals

Washington, D.C. – June 22, 2011 – The administration today issued further guidance on an Affordable Care Act regulation that gives consumers the right to an external appeal if an insurance claim is denied. While the regulation makes strides in providing some clarification for consumers to resolve disputes with their health plan, the American Cancer Society Cancer Action Network (ACS CAN) has significant concerns about barriers to appeals that continue to exist. ... affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people ...

ACS CAN Releases 13th Annual How Do You Measure Up Report

... was not all good as many states are still failing to pass legislation that would prevent cancer, reduce youth smoking, improve access to cancer care and significantly reduce health care costs. Those are the conclusions of ACS CAN's 13th annual How Do You Measure Up Report. The report, released at the recent National Conference ...

Patient Groups Applaud Progress, Call on Congress to Permanently End Surprise Medical Billing

... The 31 undersigned organizations, representing millions of patients and consumers across the country who face serious, acute, and chronic health conditions, applaud Congressional committee leaders for reaching a bicameral and bipartisan agreement to address surprise medical billing ... can work quickly to enact this bipartisan legislation that will address the ever growing problem of surprise billing and lower patients’ health care costs.   ALS Association American Cancer Society Cancer Action Network American Diabetes Association American Heart Association American ...

Lawmakers Vote to Reauthorize Medicaid Expansion for Granite Staters

... healthcare will continue for the next seven years – and hopefully beyond. “Medicaid is a lifeline for thousands of families who without health insurance would not have access to the screening, early detection, treatment, and follow-up care they need. On behalf of cancer patients, survivors, and countless other Granite Staters who need access to affordable healthcare, ACS CAN applauds New Hampshire lawmakers for putting public health first and reauthorizing Medicaid expansion.” Throughout the legislative session, cancer patients and survivors from around New Hampshire ...

Senator Christopher J. Dodd (D-CT) Announces Early Stage Prostate Cancer Diagnosis

... chief medical officer. "Our thoughts and well wishes are with Senator Dodd and his family. Senator Dodd has long been a champion of public health and is a leader in the effort to pass comprehensive health care reform, having assumed the leadership of the Senate Health, Education, Labor and Pensions Committee on behalf of Committee Chair Senator ...

Analysis of Marketplace Cancer Drug Coverage Shows Consumers Face Information Barriers on Cost and Coverage

Washington, D.C., February 22, 2017—Cancer patients trying to select the best health insurance plan through the market places continue to face challenges in determining prescription drug coverage and cost-sharing information ... and quantity limits - on common cancer drugs. ACS CAN recommends several policies that could improve drug coverage and transparency in any health care system. These include monitoring formularies to ensure plans are not discriminating against patients with high-cost conditions like cancer; ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy